Site of Health  Ministry
Site of Brazilian Government

National System of Sanitary Surveillance
Generic Drugs
Medicine Bioavailability Bioequivalence Centers
Travelers Information
Severe Acute Respiratory Syndrome

Legislation

Resolution - RDC nº 103, of May 8, 2003
Federal Employee Gazette of 13/5/2003


The Collegiate Board of Directors  of the Brazilian Sanitary Surveillance Agency, in the use of the attribution vested in it by article 11, clause IV, of the Regulation of  ANVISA approved by Decree n. 3.029, of April 16, 1999, c/c article 111, clause I, item " b ", paragraph 1 of the Bylaws approved by Administrative Order n. 593, of  August 25, 2000, published in the Federal Employee Gazette of December 22, 2000, in meeting held on May 5, 2003,

whereas Law n. 6.360, of September 23, 1976;

whereas Decree n. 79.094, of  January 5, 1977;

whereas Law n. 9.787, of  February 10, 1999;

whereas Decree n. 3.181, of  September 23, 1999;  

whereas Resolution n. 41, of April of 28, 2000;

whereas the Technical Regulation  approved by Resolution RDC n. 84, of March 19, 2002 and the Handbook of Good Practices in Bioavailability/Bioequivalence; 

whereas the need to regulate the procedures to be followed by the national and international Centers interested in carrying out Bioavailability/Bioequivalence assays for the purpose of medicine registration; 

whereas the necessity to verify “in Ioco” the proceedings technician, operational, scientific and ethical adopted in the accomplishment of the studies of Bioavailability/Bioequivalence for medicines; 

whereas the need to standardize the actions of the National Sanitary Surveillance System; 

has adopted the following Resolution of the Collegiate Board of Directors and I, Director-Chairman, deputy, determine its publication:

TITLE I

GENERAL CONSIDERATIONS

Article 1. The Centers that carry out Bioavailability/Bioequivalence studies for the purpose of medicine registration shall observe the rules and technical regulations in force.

Article 2. For the purposes of this RDC, the following definitions shall be adopted: 

Center of Bioavailability/Bioequivalence of Medicines:  research institution which carries out at least one of the three phases that comprise the study in question - Clinical, Analytical and Statistical –becoming responsible, technically and legally, for the authenticity of the data and information of the entire process, in the terms of this Resolution.

Responsible for the Phase:  natural person qualified by his or her professional education, training and experience, responsible for the correct execution and/or coordination of the study phase assigned to him or her. 

Coordinator of the Center:  natural person responsible for the administrative coordination of the phases under the competence of the Center. 

Main Researcher:  natural person qualified by his or her professional education, training and experience, responsible for the technical-scientific coordination of the Bioavailability/Bioequivalence study and for the preparation of its final report of exactly, in the terms of the current legislation.  

TITLE II

CERTIFICATION OF GOOD PRACTICES IN BIOAVAILABILITY/BIOEQUIVALENCE OF MEDICINES

Article 3.  The  Bioavailability/Bioequivalence studies carried out in the country and abroad shall only be accepted, for the purpose of medicine registration, when carried out by Centers that are properly Certified by the Brazilian Sanitary Surveillance Agency. 

Article 4.  In order to apply for the  Certification of Good Practices in Bioavailability/Bioequivalence, the interested part shall fill out the Application Form, according to  Annex I, available at:  http://www.anvisa.gov.br. 

Paragraph 1. The form shall be filled out and instructed by the documents requested, and later forwarded to the headquarters of the Brazilian Sanitary Surveillance Agency/General Office of  Inspection and Control of Medicines and Products. 

Paragraph 2.  The Center of Bioavailability/Bioequivalence is solely responsible for filling out and sending  the Application Form containing the information regarding  the activities carried out by the Center.

Paragraph 3. The Sanitary Surveillance Inspection Fee is provided for in Resolution - RDC n. 23, of  February 6,  2003.

Paragraph 4.  After evaluation of the Application Form and other documents for the Certification, the General Office of Inspection and Control of Medicines and Products shall schedule  inspection at the  unit(s).  For the purposes of inspection, the items set forth in the  Guidelines for Inspection at Centers of Bioavailability/Bioequivalence of  Medicines, according to Annex II

Article 5. The Certification referred to in  the previous article, issued according to Annex III,  shall depend on proof of compliance with the national and international standards for Clinical Research, the technical regulations in force pertaining to assays of Bioavailability/Bioequivalence of  medicines and  the Guidelines for Inspection of Good Practices in Bioavailability / Bioequivalence by the requesting Center.

TITLE III

OUTSOURCING/LEASING

Article 6. In order to outsource, the contracting Center shall forward to GGIMP/ANVISA the  Form for Outsourcing, according to Annex IV 

Paragraph1. The Form for  Outsourcing shall include the activities that are to be carried  out by the contracting Center and the contracted Center, including knowledge of the terms of the operation by the sponsoring industry. 

Paragraph 2.  Outsourcing may only be done with Centers duly certified by  ANVISA.  The phase outsourcing contract shall be filed at the  Center responsible for the study. 

Paragraph 3. The outsourcing contract does not exempt the contractor from its technical and legal responsibilities regarding the procedures adopted  and the results obtained. 

Paragraph 4.  The phase outsourcing contract shall be carried out by research protocol or by  set of protocols.

Paragraph 5. The sub-contracting of the outsourced phase is prohibited. 

Paragraph 6.  For the purpose of  outsourcing of phase, the contracted Center shall keep record of the documentation generated during the execution of the contracted phase and the Center responsible for the study shall keep record of the full documentation of the phases of the study. 

Article 7. The Centers of Bioavailability/Bioequivalence that carry out  the Clinical Phase shall make available an appropriate place for  confinement of subjects.  The place may belong to the Center or be leased, and at least one physician from the Center or clinical staff of the leased unit must be present while the activities are carried out.

Paragraph 1.  In the cases of leasing, the contracts may only be entered into with units that have and provide proof of adequate operational and technical  capacity, subject to inspection by ANVISA.

Paragraph 2.  The hospitalization unit  must have a sufficient number of beds, in such a way as to contemplate the correct execution of the studies, in a place that ensures the privacy and health of the subjects. 

Article 8.  In carrying out the Clinical Phase of the  Bioavailability / Bioequivalence assays, the clinical analyses laboratory tests shall be carried out in laboratories that possess valid Sanitary License, issued by the competent sanitary authority.  They might also be evaluated by the technical body of ANVISA,  regarding the standards of Good Practices of Clinical Laboratory. 

Only paragraph.  In the cases of the laboratories evaluated, the result of the evaluation will be considered with a view to  registration of those that shall  carry out the clinical analyses tests of the phase.  

TITLE IV

TRANSITORY AND FINAL DISPOSALS

Article 9. The legal effects referring to the approval of the Centers shall only hold after the publication of the Certification in the Federal Employee Gazette.  ANVISA shall  provide the updated list of Certifications on its website. 

Article 10.  The certified Centers shall be monitored through regular inspection or at any time, in cases of charge or  quality deviation. 

Article 11.  All the  documentation pertaining to the  Bioavailability/Bioequivalence assays shall remain  filed and available for at least 15 (fifteen) years, as from the date of conclusion of the study. 

Article 12.  The  national Centers shall forward to GGIMP/ANVISA/MS, obligatorily, Monthly Report of Assay of Bioavailability/Bioequivalence of Medicines, according to Annex V available at:  http//www.anvisa.gov.br.

Article 13. The  national and international Centers previously qualified, according to the list available at the website of ANVISA, are granted 120 (one hundred and twenty) days, as from the date of publication of this RDC, to adapt to the conditions set forth hereby, and shall apply for the Certification of Good Practices in Bioavailability/Bioequivalence of  Medicines. 

Only paragraph.  After the abovementioned period of time, only the Bioavailability/Bioequivalence studies, for the purpose of medicine registration, carried out by duly  certified entities shall be accepted, with respective publication in the Federal Employee Gazette. 

Article 14.  Failure to comply with the provisions set forth in this Resolution, including evidence of errors in the execution of the activities under the responsibility of the Center, as well as  other  cases not provided for by this rule, shall  be evaluated by the  General Office of Inspection and Control of Medicines and Products/ANVISA. 

 Article 15. Articles  1, 2, 3, 5, 6, Annex I – item 3.a and Statistical Phase – item 2 and Annex II of Resolution n. 41, of  April 28, 2000, are hereby revoked: 

Article 16. This Resolution enters into force on the date of its publication. 

CLAUDIO MAIEROVITCH PESSANHA ENRIQUES

 Annex I – Application Form for Certification of Good Practices in Bioavailability/ Bioequivalence of  Medicines. (in word) (in english)

Annex II – Guidelines for Inspection at Centers of  Bioavailability/Bioequivalence of  Medicines. (in word) (in portuguese)

Annex III – Certificate of Good Practices of Bioavailability/Bioequivalence of Medicines. (GIF format) (in portuguese)

Annex IV – Form for Outsourcing of Phase for Assays of Bioavailability/Bioequivalence of Medicines. (in word) (in portuguese)

Annex V – Form for Monthly Report of Assays of Bioavailability/Bioequivalence of  Medicines. (in word) (in portuguese)

CLASSIFICATION  OF ITEMS OF THE INSPECTION GUIDELINES

The criteria established for classification is based on the inherent potential risk to each item in relation to the quality and safety of the tests and safety of the worker in his interaction with activities carried out, guaranteeing, in this manner, the reliability of results obtained.

I.  INDISPENSABLE (I): An INDISPENSIBLE item is one that meets the recommendations of Good Practices of Bioavailability/Bioequivalence of Medicines, that can influence on a critical level the quality or safety of assays and  the safety of workers in their interaction with products and processes during the studies. Define by YES or NO.

II. NECESSARY (N): A NECESSARY item is one that meets the recommendations of Good Practices of Bioavailability/Bioequivalence of Medicines, that can influence on a less critical level the quality or safety of assays and  the safety of workers in their interaction with products and processes during the studies. Define by YES or NO.

Note: A NECESSARY item not met upon inspection, shall hence be classified as INDISPENSABLE in the next inspections.

 

III. RECOMENDABLE (R): A RECOMMENDABLE item is one that meets the recommendations of Good Practices of Bioavailability/Bioequivalence of Medicines, that can influence on a not so critical level the quality or safety of assays and  the safety of workers in their interaction with products and processes during the studies. Define by YES or NO.

Note: A RECOMENDABLE item  not met upon inspection, shall hence be classified as NECESSARY in the next inspections. However, it shall never be treated as INDISPENSIBLE.

IV. INFORMATIVE (INF): An INFORMATIVE item is one that  provides descriptive information that does not affect the quality or safety of assays and the safety of workers in their interaction with products and processes during the realization of studies. It can be optionally answered by YES or NO, or in a descriptive manner.

INSPECTION GUIDELINES

1. GENERAL INFORMATION OF THE CENTER

N0

Qualification

Items

1.1

INF

Corporate name:

1.2

INF

Denomination:

1.3

INF

CNPJ: 

1.4

INF

Legal representative:

1.5

INF

Number of Certificate:

1.6

INF

Address of the administrative office:

District:

Municipality:

FU:                     ZIP:

Telephone:            Fax:

E-mail:

1.7

INF

Address of the operational unit:

Municipality:

District:

FU:                ZIP:

Telephone:       Fax:

E-mail:

1.8

INF

Coordinator of the  Center:

1.9

INF

Coordinator of the Clinical Phase:

1.10

INF

Coordinator of the Analytical Phase:

1.11

INF

Coordinator of the Statistical Phase:

1.12

INF

Quality manager:

1.13

INF

Certified Phase(s):

1.14

INF

Outsourced Phase(s) and contracted center(s):

1.15

I

Are the outsourced contracts filed appropriately and made available for inspection?

1.16

I

Are the outsourced contracts signed by entities certified by ANVISA?

1.17

INF

Operational capacity (Assays/month):

1.18

INF

Beginning of operation:

1.19

INF

Number of studies carried out until present:

2. INSPECTION DATA

N0

Qual.

Items

2.1

INF

Inspection period:

2.2

INF

Reason for inspection:

2.3

INF

Date of the last inspection:

2.4

INF

Reason for the last inspection:

2.5

INF

Persons contacted:

2.6

INF

Team of inspectors:

3. CLINICAL UNIT

3.1. GENERAL INFORMATION

Qual

Items

3.1.1

INF

Corporate Name:

CNPJ:

3.1.2

INF

Denomination:

3.1.3

INF

Street/Avenue:

District:                                         ZIP:

Municipality:                                  FU: 

E-mail:

Telephone:                         Fax:

E-mail:

3.1.4

INF

Legal Representative:

3.1.5

INF

Coordinator of the Clinical Phase:

3.1.6

INF

Sanitary license issued by the local competent body:

3.1.7

INF

Does the company have premises security license issued by the Fire Department?

3.1.8

INF

Is there more than one clinical unit for studies?

3.1.9

INF

Does the clinical unit have a Hospital Infection Control Commission?

3.1.10

INF

Number of beds available for studies:

3.2 TECHNICAL BODY

3.2.1

INF

Number of employees

 

3.2.2

INF

Physician

 

3.2.3

INF

Pharmacist

 

3.2.4

INF

Nutritionist

 

3.2.5

INF

Biologist

 

3.2.6

INF

Bio-medico

 

3.2.7

INF

Nurse

 

3.2.8

INF

Nursing assistant

 

3.2.9

INF

Laboratory Technicians

 

3.2.10

INF

Others

 

3.3. PREMISES

General Conditions

Qual

Items

3.3.1

INF

What is the physical area of the hospitalization wing?

3.3.2

INF

Are there sources of environmental pollution and contamination close to the clinical unit?

3.3.3

N

Are the vicinities of the buildings clean?

3.3.4

R

Do the external aspects of building(s) show good conservation (free from cracks, infiltration, etc.)?

3.3.5

N

Are the floors, walls and roofs suitable for the activities developed in the area?

3.3.6

N

Are the premises built in such a manner so as to allow protection against the entry of insects and other animals?

3.3.7

R

Is the lighting appropriate?

3.4. ADDITIONAL INSTALATIONS

Qual

Items

3.4.1

R

Is there a sufficient number of changing rooms for employees (related to the area and the number of employees)?

‘3.4.2

N

Are they in appropriate hygienic conditions?

3.4.3

R

Are there toilets in sufficient number for the employees (related to the area and the number of employees)?

3.4.4

N

Are they in appropriate hygienic conditions?

3.4.5

R

Is the access to the employees’ toilets separate from the  hospitalization areas?

3.4.6

N

Are there electric power generators for emergency cases?

3.5. HOSPITALIZATION WING

Qual

Items

3.5.1

I

Is the area exclusive for subjects during hospitalization periods?

3.5.2

N

Is the lighting appropriate in the hospitalization wing?

3.5.3

N

Is ventilation appropriate in the hospitalization wing?

3.5.4

INF

How is the distribution of beds, in a ward with various beds or in apartments?

3.5.5

INF

What furniture and equipment is available in the bed areas?

3.5.6

N

Are there sufficient toilets?

3.5.7

N

Are the toilets in hygienic conditions and are they provided with hot and/or cold water, soap, and towels or driers?

3.5.8

N

Is there a nursing center?

3.5.9

INF

What is the area of the ward?

3.5.10

R

Is there a room for the nursing team to rest?

3.5.11

I

Is there a physician on duty at the place of the study during the entire period of hospitalization?

3.5.12

R

Is there a room for the physician to rest?

3.5.13

N

Is there an office for assessment of subjects?

3.5.14

I

Does the clinical unit have an intensive care unit (ICU)?

3.5.15

INF

Is the ICU movable or is it part of the clinical unit?

3.5.16

I

In case of movable ICU, will it be available  at the place of hospitalization in the period of greater risk of occurrence of serious adverse effects?

3.5.17

I

In case of movable ICU, is there a previously agreed fixed unit for transfer of the subject?

3.5.18

INF

What is the distance between the hospitalization wing and the ICU?

3.5.19

INF

Is there a refectory?

3.5.20

N

Is there a leisure area reserved for subjects?

3.5.21

INF

What furniture and equipment are available in the leisure area?

 

3.6. EQUIPMENT

Qual

Items

3.6.1

R

Is the distribution of equipment/instruments arranged rationally?

3.6.2

R

Does the emergency equipment have a no-break power system?

 

3.7. CONSULTING/NURSING OFFICE

3.7.1

I

Is there a sphygmomanometer? Conditions?

3.7.2

N

Are they calibrated periodically? What type of calibration?

3.7.3

I

Is there a stethoscope? Conditions?

3.7.4

I

Are there thermometers? Conditions/

 

3.8. EMERGENCY TROLLEY

3.8.1

I

Is there an oxygen mask?

3.8.2

I

Is there an Ambu?

3.8.3

I

Is there a Laryngoscope?

3.8.4

I

Is there an intubation tube with cuff in good conditions?

3.8.5

I

Are there disposable syringes?

3.8.6

I

Are there emergency medicines? Which ones?

 

3.9.  ROOM FOR PREPARATION OF SAMPLES

3.9.1

INF

Are the samples prepared in the clinical unit or sent to another unit?

3.9.2

R

Is there a room reserved for preparation of samples?

3.9.3

N

Is there a centrifuge? Is it refrigerated? Is it calibrated?

3.9.4

N

Is there a procedure for cleaning and decontamination of the centrifuge?

3.9.5

R

Is there a freezer?

3.9.6

N

Is there temperature of the freezers recorded Are the thermometers used calibrated by a laboratory accredited by RBC (Brazilian Network of Calibration)?

3.9.7

R

Is there a refrigerator?

3.9.8

N

Is there temperature of the refrigerators recorded?

 

3.10. DOCUMENTATION

Qual

Items

3.10.1

N

Is there a clinical record of the study considering its particularities?

3.10.2

N

Do the clinical records of subjects contain all necessary data (name, age, sex, address, etc)?

3.10.3

I

Is personal data of volunteers handled within medical secrecy?

3.10.4

INF

Is the data entry system computerized or manual in the form of a protocol register?

3.10.5

N

Is there a record book for verification of dispensed medicines?

3.10.6

I

Are the medical records of subjects maintained for a minimum period of five years?

3.10.7

R

Is there a databank of subjects?

 

3.11. GOOD CLINICAL PRACTICES

3.11.1

I

Are the study protocols and amendments submitted to the Committee for Ethics in Research?

3.11.2

I

Are all protocols approved by the CER before being initiated?

3.11.3

I

Are the studies carried out in compliance with the protocol previously approved by the CER?

3.11.4

INF

Does the institution have a CER ?

3.11.5

INF

Is the researcher or any member of the research team a member of the CER? If yes, is he or she refrained from judgment of his or her own research?

3.11.6

I

Is the Research Ethics Committee registered in the CONEP?

3.11.7

I

Is the Term of Free and Informed Consent  dated and signed before any clinical procedure?

3.11.8

INF

Who is responsible for the process of obtaining the Term of Free and Informed Consent?

3.11.9

N

Are the studies carried out in accordance with national and international standards (ICH/GCP)?

3.11.10

N

Is all the information generated in the course of clinical study  registered and stored in order to guarantee a precise report?

3.11.11

N

Is there a specific field for registration of adverse effects in clinical records?

3.11.12

N

Are the adverse effects notified to the CER and ANVISA?

3.11.13

I

Is the confidentiality of the subjects’ records properly maintained?

3.11.14

N

Are the research medicines  stocked in appropriate place, with temperature and humidity control?

3.11.15

N

Are the research medicines dispensed in accordance with the study standards?

3.11.16

N

Is there insurance for the subjects?

3.11.17

N

Is there compensation for subjects that participate in studies?

3.11.18

R

Is there a procedure for monitoring of the study by the sponsor?

3.11.19

N

Is there a program for medical referral of subjects in which some illness in pre-study examinations is detected?

3.11.20

N

Is there a continuous medical treatment agreement in case of after-effects caused by adverse effects of drugs?

 

3.12. TECHNICAL BODY

3.12.1

N

Does the main researcher have experience in the conduction of clinical studies?

3.12.2

N

Does the team rely on the support of a medical body?

3.12.3

N

Does the team rely on the support of a nursing team?

3.12.4

N

Is there a program of qualification and training of employees?

3.12.5

N

Are there records referring to the qualification and training of employees?

3.12.6

N

Does the team have uniforms?

3.12.7

N

Are the uniforms clean and in  good condition?

3.12.8

N

Is the number of persons responsible for collection sufficient for the number of subjects hospitalized in each period?

3.12.9

R

In case of hospitalization of subjects carried out in non-hospital unit, is the physician supervising the study qualified in emergency care?

 

3.13. PROCEURES

3.13.1

INF

What are the tests taken by the subjects?

3.13.2

INF

What is the validity period of testes taken by the subjects?

3.13.3

N

Upon inclusion of subject in the study, is the validity period of the tests (maximum 3 months) respected?

3.13.4

INF

What is the procedure for hospitalization of subjects?

3.13.5

INF

Who receives the subjects at the place of hospitalization?

3.13.6

R

Upon hospitalization, is an inventory carried out of the subjects’ belongings, in order to make sure they are not bringing, food, medicines and others? 

3.13.7

R

Do the subjects receive a kit containing uniform and personal hygiene items for use during hospitalization?

3.13.8

R

Is there pre-consulting immediately before hospitalization of subjects?

3.13.9

N

Are the subjects hospitalized the day before intake of the medicine?

3.13.10

INF

Who is the person in-charge of receiving, protecting and storing the study medicines?

3.13.11

N

Is the procedure of preparation and cleaning of beds for hospitalization adequate?

3.13.12

INF

Who watches over the intake/administration of medicines by subjects?

3.13.13

I

Is the first blood sample taken before intake of the medicine?

3.13.14

I

Is the schedule for blood collection respected rigorously in accordance with that established in the protocol?

3.13.15

INF

What type of material is used in collection (tubes, syringes, scalpels, etc)?

3.13.16

N

Is there temperature and arterial pressure control of subjects during the period of hospitalization?

3.13.17

I

Is the menu prepared  by a nutritionist in accordance with the specifications of each study?

3.13.18

INF

What is the procedure established for meals of subjects?

3.13.19

I

Are post-study laboratory and clinical tests carried out in subjects?

3.13.20

N

Is there a complications register for the period of hospitalization of subjects?

3.13.21

INF

In case of adverse events, what procedures are adopted?

3.13.22

INF

What is the discharge procedure of the volunteer?

 

3.14. STANDARD OPERATIONAL PROCEDURES

3.14.1

N

Is there SOP for recruitment and selection of subjects?

3.14.2

N

Is there SOP for collection of samples during hospitalization?

3.14.3

N

Is there SOP for identification and preparation of samples?

3.14.4

N

Is there SOP for storage and transport of samples?

3.14.5

N

Is there SOP for hospitalization of subjects?

3.14.6

N

Is there SOP for emergency care of subjects?

3.14.7

N

Is there SOP for cleanliness and preparation of areas for hospitalization of subjects?

3.14.8

N

Is there SOP for disposal of biological and non-biological materials?

3.14.9

N

Is there SOP for receiving and control of medicines  under study?

4. CLINICAL ANALYSES LABORATORY

4.1 GENERAL INFORMATION

Qual

Items

4.1.1

INF

Corporate Name:

CNPJ:

4.1.2

INF

Denomination:

4.1.3

INF

Street/Avenue:

District:                                                        ZIP:

Municipality:                                                 FU: 

Telephone:                           Fax:

E-mail:

4.1.4

INF

Legal Representative:

4.1.5

INF

Technical Coordinator:

4.1.6

INF

Quality Manager:

4.1.7

INF

Sanitary License issued by local competent body:

4.1.8

INF

Does the company have premises security license  issued by the Fire Department?

4.1.9

INF

Does the company have the authorization from the environmental protection body? Which one?

4.1.10

INF

Tests carried out for Bioequivalence studies:

4.1.11

INF

Outsourced tests and outsourced parties:

4.1.12

INF

Number of tests/month:

 

4.2. TECHNICAL BODY

4.2.1

INF

Number of  employees

 

4.2.2

INF

Physician

 

4.2.3

INF

Pharmacist

 

4.2.4

INF

Biologist

 

4.2.5

INF

Bio-medic

 

4.2.6

INF

Chemist

 

4.2.7

INF

Nurse

 

4.2.8

INF

Technicians

 

4.2.9

INF

Others

 

 

4.3. INSTALLATIONS

General Conditions

Qual

Items

4.3.1

INF

Are there sources of environmental pollution and contamination close to the clinical unit?

4.3.2

INF

Are the vicinities of the buildings clean?

4.3.3

N

Do the external aspects of building(s) show good conservation (free from cracks, infiltration, etc.)?

4.3.4

N

Are the floors, walls and roofs suitable for the activities developed in the area?

4.3.5

N

Are the premises built in such a manner so as to allow protection against the entry of insects and other animals?

4.3.6

N

Is the lighting appropriate?

 

4.4. ADDITIONAL INSTALLATIONS

Qual

Items

4.4.1

R

Is there a sufficient number of changing rooms for employees (related to the area and the number of employees)?

4.4.2

N

Are they in appropriate hygienic conditions?

4.4.3

R

Are there toilets in sufficient number for the employees (related to the area and the number of employees)?

4.4.4

N

Are they in appropriate hygienic conditions?

4.4.5

N

Is the access to the employees’ toilets separate from the  technical areas of the laboratory?

 

4.5. DOCUMENTATION OF SUBJECTS

Qual

Items

4.5.1

N

Do the clinical records of subjects contain all necessary data (name, age, sex, address, etc)?

4.5.2

INF

Are samples identified by codes?

4.5.3

INF

Is there a different treatment of tests done by subjects? (No. of the study protocol, special identification, specific equipment, etc).

4.5.4

INF

Is the data entry system computerized or manual in the form of a protocol register?

 

4.6. SAMPLE

Qual

Items

4.6.1

INF

Where is the biological material of subjects collected?

4.6.2

R

Is the Collection Room easily accessible?

4.6.3

INF

Is the Collection Room divided into booths?

4.6.4

N

Does the Collection Room have a wash-basin for washing hands?

4.6.5

N

Is there a box for disposal perforating materials?

4.6.6

R

Is it air-conditioned?

4.6.7

I

Is the collection room found in ideal clean conditions?

4.6.8

I

Is the material used in collection disposable?

4.6.9

I

In the collection procedure, are the tubes identified adequately in a way so as to avoid exchange of samples?

4.6.10

R

Is collection done in primary tubes?

 

4.7.  SELECTION OF SAMPLES

Qual

Items

4.7.1

R

Is the Selection Room independent?

4.7.2

INF

Are samples prepared for internal transport?

4.7.3

N

Are samples prepared for external transport ?

4.7.4

INF

How are the samples sent to sectors in-charge? (with a printed work protocol, bar code)?

 

4.8. Storage

Qual

Items

4.8.1

INF

Is the analysis of these samples carried out immediately after they are received?

4.8.2

N

Are the samples stored in an adequate place and temperature?

4.8.3

N

Is there temperature control of places of storage?

4.8.4

N

Are the containers used for storage adequate?

4.8.5

INF

For how long are the samples maintained for re-analysis/counter-test?

4.8.6

N

Is the procedure for disposal  of biological material adequate?

 

4.9. EXTERNAL TRANSPORT OF SAMPLES

Qual

Items

4.9.1

INF

Is there external transport of biological samples?

4.9.2

INF

Are the samples received processed in their place of origin? 

4.9.3

N

Are thermal boxes with dry/recyclable ice for external transport of refrigerated samples?

4.9.4

INF

What is the method used for external transport of biological samples?

4.9.5

INF

What is the average duration of external transport of samples?

 

4.10. INTERNAL TRANSPORT OF SAMPLES

Qual

Items

4.10.1

INF

How is internal transport of samples done?

 

4.11. RECORD OF RESULTS OF TESTS

Qual

Items

4.11.1

INF

Are the results recorded in the work protocol?

4.11.2

INF

Are the results recorded in protocol books?

4.11.3

INF

Are the results transferred to a computerized system?

4.11.4

R

Is there an equipment interface with the system of registration of results?

4.11.5

INF

If negative, how often are results transcribed until release of the final report?

4.11.6

N

Is there a procedure for checking the transcribed results?

 

4.12. TEST REPORT

Qual

Items

4.12.1

INF

Is the test report printed directly from the computerized system?

4.12.2

N

Are there reference values?

4.12.3

N

Are the methodologies applied specified?

4.12.4

R

Is the equipment used specified?

4.12.5

I

Is the report signed by a professional in-charge?

4.12.6

INF

Is the report handed over directly to the subject or to the physician responsible for the  study?

 

4.13. TRACKING OF INFORMATION

Qual

Items

4.13.1

I

Does the laboratory information system allow tracking of results of tests carried out in subjects?

4.13.2

INF

Is there a specific filing system for data on the subjects?

 

4.14. COMPUTERIZATION/INTERFACING

Qual

Items

4.14.1

INF

Are the areas of the laboratory interconnected  by means of a network?

4.14.2

R

Is the analytical equipment interfaced in order to avoid transcriptions?

 

4.15. ORGANIZATION OF THE LABORATORY ENVIRONMENT

Qual

Items

4.15.1

R

Is the physical space divided adequately among different sectors of the laboratory?

4.15.2

R

Is the position of counters in relation to the cabinets and equipment operational?

4.15.3

R

Is the position of freezers and refrigerators operational?

4.15.4

R

Is the means of access of technicians good?

4.15.5

R

Is there adequate place for keeping glass ware of immediate use?

4.15.6

R

Is access to electric current made easy?

4.15.7

R

Is there a specification of the type of electric current?

4.15.8

N

Is the laboratory environment air-conditioned?

4.15.9

N

Is there ambient temperature control?

 

4.16. ORGANIZATION OF THE WORK COUNTER

Qual

Items

4.16.1

N

Are the counters sufficient in relation to the construction material?

4.16.2

N

Were they clean at the time of the inspection?

4.16.3

N

Are they cleaned and disinfected before and after use?

4.16.4

R

Is protection used in counters while working?

4.16.5

N

Are the SOP’s accessible to technicians close to the counters?

4.16.6

R

Is there support for automatic pipettes?

 

4.17. GOOD LABORATORY PRACTICES

Qual

Items

4.17.1

N

Is there a Quality Guarantee System, with designated staff to ensure that the responsibilities are carried out in accordance with the principles of the existing technical standards (BPL, ISO, OECD)?

4.17.2

INF

Does the quality manager have other functions in the program of the laboratory?

4.17.3

N

Does the quality management undertake internal audits?

4.17.4

INF

What is the frequency of internal audits?

4.17.5

N

Are there records of internal audits?

4.17.6

N

Is there a training program for employees of the laboratory?

4.17.7

N

Is the staff trained and guided in such a manner so as to guarantee correct and full execution of  processes and procedures defined?

4.17.8

I

Are there Standard Operational Procedures?

4.17.9

N

Are SOP’s suitable and used by the different sectors?

4.17.10

N

Is there a Quality Manual?

4.17.11

N

Does the laboratory participate in assay proficiency programs?

4.17.12

R

Is it a member of any technical-scientific  association? Which  associations?

 

4.18. STANDARD OPERATIONAL PROCEDURES

Qual

Items

4.18.1

N

Is there SOP for use and maintenance of instruments?

4.18.2

N

Is there SOP for use and maintenance of equipment?

4.18.3

N

Is there SOP for disinfection of reusable utensils?

4.18.4

N

Is there SOP for washing of glass ware?

4.18.5

N

Is there SOP for cleaning installations?

4.18.6

N

Is there SOP for collecting biological material?

4.18.7

N

Is there SOP for external transport of samples?

4.18.8

N

Is there SOP for disinfection and disposal of biological and non-biological material?

 

4.19. EQUIPMENT

Qual

Items

4.19.1

N

Has the equipment been installed according to the manufacturer’s specifications?

4.19.2

INF

Is the equipment automatic? What type of calibration?

4.19.3

N

Is the equipment calibrated regularly?

4.19.4

R

Is there a procedure for cleaning and decontaminating the equipment?

4.19.5

R

Is there preventive and corrective maintenance of equipment?

4.19.6

N

Is there a record of calibration of equipment?

4.19.7

N

Are the centrifuge(s) and thermometers certified by INMETRO or an accredited laboratory (RBC)?

4.19.8

N

Is there a temperature record  of double-boilers?

4.19.9

N

Is there a temperature record for the refrigerators?

4.19.10

N

Is there a temperature record for the freezers?

4.19.11

N

Is there a record for verification of the performance of automatic pipettes?

4.19.12

I

Are the used ferrules discarded?

4.19.13

N

Is there an electric current stabilizer?

 

4.20. REAGENTES

Qual

Items

4.20.1

I

Do the reagents have a lot number and validity date?

4.20.2

I

Are the reagents within the validity period?

4.20.3

N

Is the storage of reagents in the laboratory for immediate use adequate?

4.20.4

N

Is the storage of reagents done in ideal conditions of temperature and humidity?

4.20.5

N

Are there temperature and humidity records books of the places of storage? Are the thermometers certified by  INMETRO or accredited laboratory (RBC)?

4.20.6

INF

Are there refrigerators?

4.20.7

INF

Are there freezers?

4.20.8

R

Is there a  stock control book?

4.20.9

INF

What is the system used for obtaining reagent water?

4.20.10

N

Does the laboratory carry out physical-chemical and microbiological tests for quality control of reagent water?

4.20.11

N

Is there proper labeling of reagent-solutions prepared in the laboratory?

 

4.21. BIOSAFETY

Collective Protection

Qual

Items

4.21.1

N

Is there a Biosafety Program?

4.21.2

N

Is the technical body of the laboratory submitted periodically to health examinations?

4.21.3

N

Is there a Vaccination Program of employees?

4.21.4

N

Is there a Waste Treatment Program?

4.21.5

R

Is decontamination of biological waste produced during laboratory activities carried out?

4.21.6

R

Is care taken for conditioning and final disposal of chemical waste?

4.21.7

R

Is care taken for conditioning and final disposal of non-contaminated waste?

4.21.8

I

Is there an emergency shower and eye-wash?

4.21.9

N

Are Fire Extinguishers? Are they within the validity period?                                       

4.21.10

N

Is prevention and notification of accidents done?

4.21.11

N

Are adequate containers used for disposal of broken glass ware and perforating and cutting material?

4.21.12

R

Are there educative signs warning about risks?

4.21.13

N

Is there information on how to act in case of emergency, such as: hospital telephone number, proto-help and fire brigade?

4.21.14

R

Are first-aid boxes available in case of accidents?

 

4.22. INDIVIDUAL PROTECTION

Qual

Items

4.22.1

I

Does the laboratory provide IPE (Individual Protection Equipment) and train employees to use it?

4.22.2

N

Do the employees use long jackets with long sleeves?

4.22.3

N

Do the employees use disposable gloves?

4.22.4

N

Do the employees use protective goggles or facial protection?

4.22.5

N

Do the employees use masks?

4.22.6

N

Do the employees use closed shoes or protective shoes?

4.22.7

N

Do the employees use clothes that protect the legs (long trousers)?

4.22.8

R

Is the laboratory responsible for washing uniforms used by the employees?

 

4.23. STOREROOM

General Conditions

Qual

Items

4.23.1

N

Is the physical area appropriate for the amount of material stocked?   

4.23.2

N

Is the floor, walls and roof suitable for storage of materials?

4.23.3

N

Are they in good condition?

4.23.4

N

Were they clean at the time of the visit?

4.23.5

R

Is there a program of DDT spraying?

4.23.6

INF

Was evidence of presence of the above-mentioned animals noticed?

4.23.7

R

Is the lighting appropriate?

4.23.8

N

Are the temperature and humidity in accordance with the parameters established for materials and products stored?

4.23.9

N

Is there temperature and humidity controlling apparatus? Are the thermometers certified by INMETRO or accredited laboratory (RBC)?

4.23.10

N

Is there record of  temperature and humidity control?

4.23.11

INF

Is there need for a cold room or refrigerators and freezers?

4.23.12

N

Are there temperature record books for the cold room or for the refrigerators and freezers?

 

4.24. AREAS OF ACTION

Qual

Items

4.24.1

INF

Are tests carried out in the area of Biochemistry?

4.24.2

INF

Are tests carried out in the area of Hematology?

4.24.3

INF

Are tests carried out in the area of Immunology?

4.24.4

INF

Are tests carried out in the area of Parasitology?

5. ANALITICAL UNIT

5.1 ANALYTICAL LABORATORY

General Information

Qual

Items

5.1.1

INF

Corporate Name:

CNPJ:

5.1.2

INF

Denomination:

5.1.3

INF

Street/Avenue:

District:                               ZIP:

Municipality:                        FU: 

E-mail:

5.1.4

INF

Is the laboratory composed of more than one unit? (If yes, inform the address of the other units and specify the attributions of each unit)

5.1.5

INF

Street/Avenue:

District:                               ZIP:

Municipality:                        FU:  

E-mail:

Attributions:

5.1.6

INF

Legal Representative:

5.1.7

INF

Coordinator of the Analytical Phase:

5.1.8

INF

Quality Manager:

5.1.9

INF

Does the company have premises security license issued by the Fire Department?

5.1.10

INF

Does the company have authorization from the environmental protection body?

5.2. TECHNICAL BODY

5.2.1

INF

Number of  employees

 

5.2.2

INF

Physician

 

5.2.3

INF

Pharmacist

 

5.2.4

INF

Biologist

 

5.2.5

INF

Bio-medic

 

5.2.6

INF

Chemist

 

5.2.7

INF

INF technicians

Technicians

 

5.2.8

INF

Others

 

5.3. INSTALLATIONS

General Conditions

Qual

Items

5.3.1

INF

What is the physical area of the laboratory?

5.3.2

INF

Are there sources of environmental pollution and contamination close to the company?

5.3.4

N

Are the vicinities of the buildings clean?

5.3.5

N

Do the external aspects of building(s) show good conservation (free from cracks, infiltration, etc.)?

5.3.6

N

Are the premises built in such a manner so as to allow protection against the entry of insects and other animals?

5.3.7

N

Are the floors, walls and roofs suitable for the activities developed in the area?

5.3.8

INF

Is the area exclusive for analysis of biological material?

5.3.9

N

Is access restricted to employees?

5.3.10

N

Is the lighting appropriate?

5.3.11

N

Is the air-conditioning adequate? Is there control and  Record of temperature and humidity with thermometer certified by INMETRO or accredited laboratory (RBC)?

 

5.4. ADDITIONAL INSTALLATIONS

Qual

Items

5.4.1

R

Is there a sufficient number of changing rooms for employees (related to the area and the number of employees)?

5.4.2

N

Are they in appropriate hygienic conditions?

5.4.3

R

Are there toilets in sufficient number for the employees (related to the area and the number of employees)?

5.4.4

N

Are they in appropriate hygienic conditions?

5.4.5

R

Is the access to the employees’ toilets separate from the technical areas of the laboratory?

5.4.6

INF

Are there electric power generators for emergency cases?

 

5.5. ORGANIZATION OF THE LABORATORY SPACE

Qual

Items

5.5.1

R

Is the physical space distributed adequately for carrying out  the laboratory activities?

5.5.2

R

Is the position of counters in relation to the cabinets and equipment operational?

5.5.3

R

Is the position of freezers and refrigerators operational?

5.5.4

R

Is the means of access of technicians good?

5.5.5

R

Is there adequate place for keeping glass ware of immediate use?

5.5.6

R

Is access to electric current made easy?

5.6. ORGANIZATION OF THE WORK COUNTER

Qual

Items

5.6.1

N

Are the counters sufficient in relation to the construction material?

5.6.2

N

Were they clean at the time of the inspection?

5.6.3

N

Are the SOP’s accessible to technicians?

5.6.4

R

Is there support for automatic pipettes?

 

5.7. GOOD LABORATORY PRACTICES

Qual

Items

5.7.1

N

Is there a Quality Guarantee System, with designated staff to ensure that the responsibilities are carried out in accordance with the principles of the existing technical standards (BPL, ISO, OECD)?

5.7.2

N

Is the Quality Program available to all the employees?

5.7.3

N

Does the laboratory have a quality manager?

5.7.4

INF

Does the quality manager have other functions in the routine of the laboratory?

5.7.5

N

Does the quality management undertake internal audits?

5.7.6

N

Are internal audits undertaken at least once a year?

5.7.7

N

Are there records of internal audits?

5.7.8

I

Does the coordinator of the analytical phase have qualification and experience regarding the activities he or she  performs?

5.7.9

R

Is there a training program for employees of the laboratory?

5.7.10

N

Are there records of the training and qualification of each employee?

5.7.11

N

Is the staff trained and guided in such a manner so as to guarantee correct and full execution of  processes and procedures defined?

5.7.12

N

Are new laboratory procedures only implemented after full evaluation and approval by the Quality Guarantee?

5.7.13

N

Does the  laboratory have an organization chart?

5.7.14

I

Does  it have Standard Operational Procedures?

5.7.15

N

Are the SOP’s appropriate and are they used by different sectors?

5.7.16

N

Does the Laboratory have records in different sectors?

5.7.17

N

Is there a Quality Manual?

5.7.18

R

Is the quality manual easily accessible to the technical body of the laboratory?

5.7.19

N

Does the quality manual concern the individual attributions of the technical and management body?

5.7.20

INF

Does it have the certificate of a competent body? Which bodies?

 

5.8. STANDARD OPERATIONAL PROCEDURES

Qual

Items

5.8.1

N

Is there SOP for transporting and receiving samples?

5.8.2

N

Is there SOP for storage of samples?

5.8.3

N

Is there SOP for identification of samples?

5.8.4

N

Is there SOP for washing of glass ware?

5.8.5

N

Is there SOP for use, maintenance and validation of chromatographic systems?

5.8.6

N

Is there SOP for validation of the analytical method?

5.8.7

N

Is there SOP for studies of stability of drugs in biological liquids?

5.8.8

N

Is there SOP for the use and maintenance of the pH-meter?

5.8.9

N

Is there SOP for use and maintenance of refrigeration systems?

5.8.10

N

Is there SOP for use and maintenance of scales?

5.8.11

N

Is there SOP for use and maintenance of water systems?

5.8.12

N

Is there SOP for the sequence of analytical runs?

5.8.13

N

Is there SOP for use and maintenance of pipettes?

5.8.14

N

Is there SOP for disinfection and disposal of biological and non-biological material?

5.8.15

N

Is there SOP for assessment of the quality of chromatograms? 

5.8.16

N

Is there SOP for establishing the criteria for re-analysis of samples?

5.8.17

N

Is there SOP for the preparation of solutions and standards of usage?

5.8.18

N

Is there SOP for pharmacokinetic analysis of data obtained?

5.8.19

N

Is there SOP for storage of the study documentation?

 

5.9. EQUIPMENT

Qual

Items

5.9.1

INF

What equipment is used for analysis of samples?

5.9.2

R

Is there a procedure for disinfection of equipment?

5.9.3

R

Is the operation manual of each equipment available in the laboratory?

5.9.4

R

Is the distribution of equipment/instruments arranged in a rational manner?

5.9.5

R

Is there an electric current stabilizer?

5.9.6

N

Does the laboratory equipment have a no-break power system?

 

5.10. CHROMATOGRAPHIC SYSTEMS

5.10.1

I

Is the chromatography  equipment Certified/Qualified periodically?

5.10.2

INF

How often?

5.10.3

INF

What is the date of the last Certification/Qualification carried out in the chromatography equipment?

5.10.4

N

Is the Certification/Qualification carried out by qualified company?

5.10.5

N

Is there a preventive and corrective maintenance program for this equipment?

5.10.6

N

Is there a record for preventive and corrective maintenance?

5.10.7

N

Is the chromatographic equipment adequately installed?

5.10.8

N

Are there usage, maintenance and storage procedures of chromatographic columns?

5.10.9

INF

Are the columns used for more than one study?

5.10.10

I

Is the ideal temperature range adhered to for operation of the equipment?

 

5.11. REFRIGERATION/AIR-CONDITIONING SYSTEMS

5.11.1

INF

What is the temperature specification of the freezers?

5.11.2

N

Is there a temperature record for freezers?

5.11.3

INF

Do the freezers have identification?

5.11.4

N

Is the storage capacity of freezers adhered to?

5.11.5

N

Is there a temperature record for refrigerators?

5.11.6

I

Are there alternative procedures in case of an energy shortage in such a way so as to preserve the content of freezers and refrigerators?

5.11.7

N

Are thermometers installed adequately in the refrigeration systems?

5.11.8

N

Is there a room temperature record?

5.11.9

N

Is there a hygrometer and an ambient humidity record?

5.11.10

R

Is there a procedure for preventive and corrective maintenance of air-conditioning equipment?

 

5.12. WATER SYSTEM

5.12.1

INF

What equipment is used for purification of water?

5.12.2

INF

Is there a place for storage of purified water?

5.12.3

INF

If yes, for how long does the water remain stored?

5.12.4

N

Is the water used  submitted to quality control?

5.12.5

INF

How often?

5.12.6

N

Is there a record for quality control of water?

5.12.7

R

Is there a procedure for preventive and corrective maintenance of water purification equipment?

5.12.8

N

Is there a record for maintenance of the water treatment system?

 

5.13. ANALYTICAL SCALE

5.13.1

N

Is the scale certified by INMETRO or accredited laboratory (Brazilian Calibration Network)?

5.13.2

N

Is the analytical scale installed according to the manufacturer’s recommendations?

5.13.3

N

Is there a standard operational procedure for the use of the analytical scale?

5.13.4

INF

Is there a procedure for preventive and corrective maintenance of the analytical scale?

5.13.5

INF

Is the calibration verification procedure carried out daily?

5.13.6

N

Is there a record of calibrations carried out?

 

5.14. pH METER

5.14.1

I

Does the analytical laboratory have a pH meter?

5.14.2

N

Is there a procedure for the use of the pH meter?

5.14.3

R

Is there a procedure for preventive and corrective maintenance of the pH meter?

5.14.4

N

Is there a record of calibration of the pH meter?

5.14.5

N

Is the pH meter checked for at least two pH values?

5.14.6

N

Are the verification buffers stored according to the manufacturer’s recommendations?

 

5.15. CENTRIFUGE

5.15.1

N

Is the centrifuge installed according to the manufacturer’s recommendations?

5.15.2

R

Does the centrifuge have a refrigeration system?

5.15.3

R

Is there a standard operational procedure for use of the centrifuge?

5.15.4

R

Is there a procedure for preventive and corrective maintenance of the centrifuge?

5.15.5

R

Is there a record for maintenance of the centrifuge?

5.15.6

N

Is there a procedure for cleaning and decontamination of the centrifuge?

 

5.16. GLASS WARE AND PIPETTES

5.16.1

R

Are tests carried out for verification of the quality of the glass ware washing process?

5.16.2

R

Is the volumetric glass ware certified by INMETRO or accredited laboratory (Brazilian Calibration Network)?

5.16.3

R

Is the volumetric glass ware kept in an adequate place?

5.16.4

INF

What is the type of material of vials used for the analytical runs?

5.16.5

N

Are used vials discarded?

5.16.6

N

Are the automatic pipettes certified?

5.16.7

R

Is there a procedure for the use of automatic pipettes?

5.16.8

INF

Is the frequency of maintenance / calibration of the automatic pipettes at least annual?

5.16.9

N

Is there a record of maintenance/calibration of automatic pipettes?

5.16.10

N

Is there a procedure for cleaning and decontamination of pipettes/micropipettes?

5.16.11

I

Are the used ferrules discarded?

 

5.17. REAGENTS

Qual

Items

5.17.1

I

Do the reagents have a lot number and a validity date?

5.17.2

I

Are the reagents within the validity period?

5.17.3

N

Is the storage of reagents done according to manufacturer’s recommendations?

5.17.4

N

Does the laboratory have a temperature and humidity record of the places of storage?

5.17.5

R

Does the laboratory have stock control books?

5.17.6

R

Are the reagents separated by classes (inflammable, non-inflammable, oxidizing, acids and bases)?

5.17.7

N

Does the laboratory have an exhaust hood for handling of reagents?

5.17.8

N

Is proper labeling used for solutions-reagents prepared in the laboratory?

 

5.18. MOBILE PHASE

5.18.1

INF

What degree of purity of solvents is used for preparation of the mobile phase?

5.18.2

INF

What degree of purity of additives is used for the preparation of the mobile phase (salts, acids, buffer)?

5.18.3

I

Is the water used in the preparation of the mobile phase of type 1?

5.18.4

R

Is the mobile phase prepared daily?

5.18.5

INF

Is the pH of the mobile phase previously checked for the realization of the analytical runs?

5.18.6

R

Is filtration of the mobile phase done?

5.18.7

INF

What are the methods used for filtration of the mobile phase?

5.18.8

R

Is degassing of the mobile phase done?

5.18.9

INF

What is the procedure for degassing of the mobile phase?

5.18.10

INF

What cleaning procedure is adopted for cleaning the filter of the reservoir of the mobile phase?

 

5.19. REFERENCE CHEMICAL SUBSTANCES

5.19.1

INF

Are Pharmacopoeic Reference Chemical Substances used?

5.19.2

I

Do the Work Chemical Substances (secondary standards) have an analysis report?

5.19.3

INF

Are the secondary standards provided by an institution independent from the contracting company?

5.19.4

N

Are the reference standards stored in adequate place?

5.19.5

R

Is there stock control for reference substances?

5.19.6

N

Is there a procedure for discarding expired standards?

 

5.20. SAMPLES

Qual

Items

5.20.1

N

Is there record for receiving of samples?

5.20.2

R

Does the laboratory have a check list for receiving of samples (temperature record, identification and data of samples, packaging conditions, etc)?

5.20.3

INF

What is the storage temperature of biological samples?

5.20.4

I

Are the biological samples stored in an adequate manner in freezers? Is temperature control carried out with thermometers certified by INMETRO or accredited laboratory (RBC)?

5.20.5

I

Do the samples have adequate labeling containing all data necessary for their identification?

5.20.6

INF

Are the biological samples aliquoted? What is the procedure adopted?

5.20.7

N

In case of re-analysis of samples, is it properly justified and registered?

5.20.8

N

In case of loss of samples, is it properly justified and registered?

 

5.21. EXTERNAL TRANSPORT OF SAMPLES

Qual

Items

5.21.1

INF

Is there external transport of biological samples?

5.21.2

INF

Are the biological samples pre-processed in their place of origin?

5.21.3

N

Is there prior knowledge of the hours and dates of road or air dispatch?

5.21.4

N

Are thermal boxes with adequate refrigeration material for the duration of transport of biological samples?

5.21.5

R

Do the biological samples come with a temperature recording device during the course of travel?

5.21.6

INF

What is the method used for external transport of samples?

5.21.7

INF

What is the average duration of external transport of samples?

 

5.22. INTERNAL TRANSPORT OF SAMPLES

Qual

Items

5.22.1

INF

How is internal transport of samples carried out?

 

5.23. VALIDATION OF ANALYTICAL METHODS

NAME OF STUDY AUDITED:

Qual

Items

5.23.1

I

Does the laboratory have complete records of validations?

5.23.2

I

Are accuracy and precision studies carried out within acceptable limits?

5.23.3

N

Are analyses done for determination of the limit of quantification?

5.23.4

N

Is a level of recovery of the method determined?

 

5.24. STABILITY

5.24.1

I

Are studies of stability of freezing and thawing cycles of samples carried out?

5.24.2

I

Are short-term stability studies carried out? 

5.24.3

I

Do the stability studies concern the period between collection and analysis of the last study sample (long-term stability)?

5.24.4

I

Is a study of drug stability in stock solutions carried out?

5.2425

I

Is post-processing stability study carried out?

 

5.25. BIOSAFETY

Collective Protection

Qual

Items

5.25.1

R

Is there a Biosafety Commission?

5.25.2

R

Does the technical body of the laboratory undergo health tests periodically?

5.25.3

R

Is there a Vaccination Program for employees?

5.25.4

N

Is there a Waste Treatment Program?

5.25.5

N

Is decontamination of biological waste produced during laboratory activities carried out?

5.25.6

N

Is care taken for conditioning and final disposal of chemical waste?

5.25.7

R

Are adequate containers used for discarding broken glass ware?

5.25.8

N

Is there an emergency shower and eye-wash?

5.25.9

N

Are Fire Extinguishers, sand buckets and granulated absorbents available?                                        

5.25.10

N

Is prevention and notification of accidents done?

5.25.11

R

Are there educative signs for preventing  risks?

5.25.12

N

Is there information on how to act in case of emergency, such as: hospital telephone, proto-help and fire brigade?

5.25.13

R

Are first-aid boxes available in case of accidents?

 

5.26. INDIVIDUAL PROTECTION

Qual

Items

5.26.1

N

Does the laboratory train and guide the employees in the use the IPE (Individual Protection Equipment)?

5.26.2

N

Do the employees use long jackets with long sleeves?

5.26.3

N

Do the employees use disposable gloves?

5.26.4

N

Do the employees use protective goggles or facial protection?

5.26.5

R

Do the employees use masks?

5.26.6

N

Do the employees use closed shoes or protective shoes?

5.26.7

N

Do the employees use clothes that protect the legs (long trousers)?

5.26.8

R

Is the laboratory responsible for washing uniforms used by the employees of the laboratory?

 

5.27. DOCUMENTATION

Qual

Items

5.27.1

INF

What are the methods for filing the chromatograms of studies and remaining documents?

5.27.2

R

Is access of documentation of studies made easy?

5.27.3

I

Is the study documentation filed for at least 5 years?

6. STATISTICS

6.1 GENERAL INFORMATION

Qual

Items

6.1.1

INF

Name of the Coordinator of the Statistical Phase:

6.1.2

INF

Qualification of the Coordinator:

6.1.3

N

Is the Coordinator qualified in the area of Statistics?

6.1.4

INF

Does the Center have advice from a statistician?

6.1.5

INF

Attributions of the Coordinator of the Phase:

6.1.6

INF

Place of execution of the statistical phase:

Street/Avenue:                          ZIP:

District:

Municipality:                            FU: 

E-mail:

6.1.7

INF

Software used:

 

6.2. DESIGN OF THE STUDY

Qual

Items

6.2.1

N

Does the coordinator participate in planning of the study? (Decisions on the design of the experiment, size of the sample, etc)

6.2.2

N

Are there criteria for the definition of the design of the experiment? Which ones?

6.2.3

I

Is the method of allocation of subjects for the sequence of intake of medicines randomized? What is the procedure adopted?

 

6.3 DATA MANAGEMENT

Qual

Items

6.3.1

N

Is there SOP related to execution of the Statistical Phase and/or obtaining of pharmacokinetic parameters?

6.3.2

N

Is there a procedure for the review of data obtained on collection times?

6.3.3

INF

How is transcription of data of chromatograms to work spreadsheets done?

6.3.4

INF

What is the procedure adopted in case of missing samples and/or problems in chromatograms?

6.3.5

N

Are incidents from the previous phases documented?

6.3.6

N

Does the coordinator receive information with respect to incidents from previous phases?

6.3.7

INF

How are pharmacokinetic parameters obtained?

6.3.8

INF

How many transcriptions of data are done as from the end of the analytical run of subjects?

6.3.9

N

Is there a record dated and signed for checking transcribed data?

6.3.10

INF

Is data transcription done manually or by a digital interface?

6.3.11

INF

What are the methods of filing information generated in the process?

 

6.4. STATISTICAL ANALYSIS

Qual

Items

6.4.1

R

Is preliminary (exploratory) analysis of data done before proceeding to statistical representation?

6.4.2

INF

What are the points addressed in preliminary analysis? Is there graphical representation?

6.4.3

N

What criteria are adopted for detection of atypical or conflicting values?

6.4.4

INF

What measures are adopted for detecting atypical observations?

6.4.5

N

Is data transformed for representation (ANOVA)?

6.4.6

I

In Variance Analysis, are the effects of sequence (group), of subjects within the sequence, of the period and treatment considered?

6.4.7

I

Is the ANOVA based on the experimental design adopted in the assessed study?

6.4.8

INF

Is analysis of residues after representation done?

6.4.9

R

Is some method used for establishing the presence of the effect of interaction between period and treatment (residual effect)?

6.4.10

INF

What are the methods used for determination of the reliability Interval?

6.4.11

N

Is the  software used in the statistical analysis appropriate?

 

 

 
 
Copyright 2003 - Anvisa
Ombusdman Advisory Council